TLR4 and COVID-19: These findings indicate that COVID-19 acute necrotizing encephalopathy is associated with S100A12-TLR4-induced inflammation, highlighting the importance of the pro-inflammatory S100A12 molecule for development of potential therapeutic strategies for acute necrotizing encephalopathy.